Rijneveld A, van der Holt B, de Weerdt O, et al. Randomized phase III HOVON-100 study of clofarabine combined with standard treatment in adult patients with newly diagnosed ALL. 24th Congress of EHA, abstract PS937.
Ruxolitinib bij intermediair-1 risico myelofibrose
dec 2017 | MPN, Stamceltransplantatie